Skip to main content
. Author manuscript; available in PMC: 2020 Sep 10.
Published in final edited form as: Endocr Relat Cancer. 2020 Sep;27(9):519–527. doi: 10.1530/ERC-20-0139

Table 3.

Cohort characteristics by postoperative hypotension.

Postoperative hypotension
Variable
All (n = 96)
No, median (IQR)
Yes, median (IQR)
P
Age (years), mean ± s.d. 96 37.8 ± 14.5 37.5 ± 15.6 0.937
Chromogranin A 96 196 (134–893) 328 (163–776) 0.520
24-h urine NMN f-ULN 85 2.8 (1.1–3.6) 5.0 (1.1–9.9) 0.175
24-h urine MN f-ULN 84 0.4 (0.3–1.4) 0.4 (0.2–0.8) 0.329
Plasma NMN f-ULN 96 4.1 (1.8–8.7) 7.3 (3.2–17.3) 0.018
Plasma MN f-ULN 96 0.5 (0.4–1.1) 0.5 (0.4–0.7) 0.797
Plasma dopamine f-ULN 93 0.9 (0.4–1.8) 1.1 (0.4–2.8) 0.595
Tumor max dimension (cm) 96 3.6 (2.5–5.8) 3.9 (2.5–6.3) 0.254
Number of tumors 96 1 (1–2) 2 (1–3) 0.029
Total tumor volume (cm3) 96 13.8 (4.6–45.3) 15.78 (3.8–56.9) 0.369
Duration of α-blockade (days) 96 30.0 (17.3–65.5) 38.0 (17.5–66.0) 0.377
Number of BP medications, mean ± s.d. 96 2.3 ± 0.9 2.6 ± 0.7 0.140
Preopeartive MAP 96 89.7 (80.3-94.8) 87.3 (82-95) 0.724
Preoperative SBP 96 124 (117-130) 120 (115-128) 0.361
Preoperative IVF hydration (mL), mean ± s.d. 95 1280 ± 591 1250 ± 619 0.823
Estimated blood loss (mL) 95 300 (100–800) 300 (100–800) 0.736
Surgery duration (min) 96 247 (189–386) 312 (242–365) 0.446
IO crystalloid (mL) 96 4300 (3000–6150) 4500 (3500–6000) 0.450
24-h postoperative IVF (mL) 96 2872 (2385–3544) 4058 (2871–5270) 0.001
Increase in postoperative weight (kg), mean ± s.d. 96 4.0 ± 3.7 6.4 ± 3.8 0.007
Return of bowel function (days) 96 4.0 (3.0–5.0) 4.0 (2.0–6.0) 0.425
Length of stay (days) 96 7.0 (6.0–9.0) 7.0 (6.0–9.0) 0.678

BP, antihypertensive; f-ULN, fold above upper limit of normal; IO, intraoperative; IQR, interquartile range; IVF, intravenous fluid; MAP, mean arterial pressure; max, maximum; MN, metanephrines; NMN, normetanephrine; SBP, systolic blood pressure. Bold indicates statistical significance, P<0.05.